ESLA
ESLA
NASDAQ · Biotechnology

Estrella Immunopharma Inc

$0.43
-0.05 (-10.31%)
As of Sep 28, 10:28 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +3,395.6% upside
Low Target $11.92
Average Target $15.08
High Target $19.61
Current Price $0.43
Current
$0.43
Target
$15.08
$11.92 $15.08 avg $19.61
Scenario Analysis
Bear Case
$11.92
2,663.1%
Low target
Base Case
$15.08
+3,395.6%
Avg target
Bull Case
$19.61
+4,445.7%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$3.15
-86.3% from high
52-Week Low
$0.46
+-6.3% from low
Target vs 52W High
$15.08
+378.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%